1. Home
  2. LNN vs SPTX Comparison

LNN vs SPTX Comparison

Compare LNN & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$110.82

Market Cap

1.1B

Sector

Industrials

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$20.46

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LNN
SPTX
Founded
1954
N/A
Country
United States
United States
Employees
1275
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
LNN
SPTX
Price
$110.82
$20.46
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$113.00
N/A
AVG Volume (30 Days)
130.4K
91.6K
Earning Date
04-02-2026
N/A
Dividend Yield
1.35%
N/A
EPS Growth
12.81
N/A
EPS
4.22
N/A
Revenue
$676,368,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.74
N/A
P/E Ratio
$26.32
N/A
Revenue Growth
11.41
N/A
52 Week Low
$97.27
$17.59
52 Week High
$148.00
$22.98

Technical Indicators

Market Signals
Indicator
LNN
SPTX
Relative Strength Index (RSI) 40.06 51.49
Support Level $109.79 $18.72
Resistance Level $114.63 $22.21
Average True Range (ATR) 2.83 1.44
MACD -0.48 -0.18
Stochastic Oscillator 9.82 27.67

Price Performance

Historical Comparison
LNN
SPTX

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: